4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001415889-25-009604
Director bought 35,640 shares at $0.56 ($19,958)
From the SEC's structured data for this filing
Trades in this filing
BRAWLEY OTIS W · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-31 | Purchase : show line 1 in the form | +35,640 | $0.56 | $19,958 | 35,640 | D |
| Open-market purchases · 35,640 sh · avg $0.56 · $19,958 | ||||||
Loading xslF345X05/form4-04022025_070458.xml…